Real-World Safety and Effectiveness of Dimethyl Fumarate in Black or African American Patients with Multiple Sclerosis: 3-Year Results from ESTEEM

INTRODUCTION: Black or African American (black/AA) patients with multiple sclerosis (MS) are reported to exhibit greater disease severity compared with non-black or non-AA patients. Whether differences exist in response to MS disease-modifying therapies remains uncertain, as MS clinical trials have...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Mitzi J., Amezcua, Lilyana, Okai, Annette, Okuda, Darin T., Cohan, Stanley, Su, Ray, Parks, Becky, Mendoza, Jason P., Lewin, James B., Jones, Cynthia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606389/
https://www.ncbi.nlm.nih.gov/pubmed/32472386
http://dx.doi.org/10.1007/s40120-020-00193-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606389/
https://www.ncbi.nlm.nih.gov/pubmed/32472386
http://dx.doi.org/10.1007/s40120-020-00193-5

Ejemplares similares